ALT
Price
$3.50
Change
-$4.21 (-54.60%)
Updated
Jun 27 closing price
Capitalization
283.87M
39 days until earnings call
TGTX
Price
$36.72
Change
-$1.23 (-3.24%)
Updated
Jun 27 closing price
Capitalization
5.83B
37 days until earnings call
Interact to see
Advertisement

ALT vs TGTX

Header iconALT vs TGTX Comparison
Open Charts ALT vs TGTXBanner chart's image
Altimmune
Price$3.50
Change-$4.21 (-54.60%)
Volume$20.04M
Capitalization283.87M
TG Therapeutics
Price$36.72
Change-$1.23 (-3.24%)
Volume$2.47M
Capitalization5.83B
ALT vs TGTX Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. TGTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and TGTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ALT: $3.50 vs. TGTX: $36.72)
Brand notoriety: ALT and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 495% vs. TGTX: 107%
Market capitalization -- ALT: $283.87M vs. TGTX: $5.83B
ALT [@Biotechnology] is valued at $283.87M. TGTX’s [@Biotechnology] market capitalization is $5.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALT is a better buy in the short-term than TGTX.

Price Growth

ALT (@Biotechnology) experienced а -50.21% price change this week, while TGTX (@Biotechnology) price change was +1.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

TGTX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.83B) has a higher market cap than ALT($284M). TGTX YTD gains are higher at: 21.993 vs. ALT (-51.456). TGTX has higher annual earnings (EBITDA): 70.5M vs. ALT (-90.75M). ALT has more cash in the bank: 150M vs. TGTX (132M). ALT has less debt than TGTX: ALT (1.59M) vs TGTX (8.98M). TGTX has higher revenues than ALT: TGTX (386M) vs ALT (20K).
ALTTGTXALT / TGTX
Capitalization284M5.83B5%
EBITDA-90.75M70.5M-129%
Gain YTD-51.45621.993-234%
P/E RatioN/A146.88-
Revenue20K386M0%
Total Cash150M132M114%
Total Debt1.59M8.98M18%
FUNDAMENTALS RATINGS
ALT vs TGTX: Fundamental Ratings
ALT
TGTX
OUTLOOK RATING
1..100
3271
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9746
PRICE GROWTH RATING
1..100
9543
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGTX's Valuation (89) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for ALT (97) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew somewhat faster than ALT’s over the last 12 months.

TGTX's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for ALT (95) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew somewhat faster than ALT’s over the last 12 months.

TGTX's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for ALT (100) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew significantly faster than ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTTGTX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALCEX14.540.11
+0.76%
Avantis U.S. Large Cap Value G
CNPAX68.320.45
+0.66%
American Funds New Perspective 529A
QSMLX17.660.04
+0.23%
AQR Small Cap Multi-Style I
OSVCX16.290.01
+0.06%
JPMorgan Small Cap Value C
AAAVX12.12-0.02
-0.16%
DWS RREEF Real Assets R6

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-54.60%
ACHV - ALT
55%
Loosely correlated
-36.47%
CRNX - ALT
50%
Loosely correlated
-0.10%
TRDA - ALT
43%
Loosely correlated
-1.57%
CCCC - ALT
42%
Loosely correlated
-7.89%
APGE - ALT
40%
Loosely correlated
N/A
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ALT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-3.24%
ALT - TGTX
40%
Loosely correlated
-54.60%
ROIV - TGTX
36%
Loosely correlated
-1.81%
CLLS - TGTX
36%
Loosely correlated
-2.54%
AVXL - TGTX
34%
Loosely correlated
-0.94%
KYMR - TGTX
34%
Loosely correlated
-3.48%
More